SPOTLIGHT -
The aim of a randomized controlled trial was to see if aerobic and strength training can successfully slow cognitive decline. The results might surprise you.
CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer Disease
Episode 88: 2023 AAN Annual Meeting Highlights
NeurologyLive® Brain Games: May 28, 2023
Special Episode: Lecanemab Approved for Alzheimer Disease
Antiamyloid Therapies Tend to Perform Better in APOE e4 Carriers
Wave Life Sciences Discontinues C9orf72-ALS and Frontotemporal Dementia Agent WVE-004 After Disappointing Phase 1b/2a Findings